HMGA2 and ovarian serous carcinoma: In high‐grade serous ovarian carcinoma (HG‐SOC), high expression of miR‐182 promotes tumorigenesis by targeting Breast Cancer Gene 1 (BRCA1), High Mobility Group AT‐Hook 2 (HMGA2), and Metastasis Suppressor 1 (MTSS1) genes [57].